Synthesis and Biological Evaluation of New Nitroimidazole Derivatives as Anti- Helicobacter pylori Agents Against Metronidazole-Resistant Strains
- PMID: 41103334
- PMCID: PMC12524007
- DOI: 10.5812/ijpr-137969
Synthesis and Biological Evaluation of New Nitroimidazole Derivatives as Anti- Helicobacter pylori Agents Against Metronidazole-Resistant Strains
Abstract
Since several Helicobacter pylori strains have become resistant to metronidazole, new nitroimidazole derivatives based on metronidazole were designed and synthesized with different substituents on imidazole nitrogen. The activity of the synthesized compounds was evaluated against 20 clinically isolated metronidazole-resistant H. pylori strains. Some synthesized compounds were effective against those metronidazole-resistant H. pylori strains. Three compounds exhibited the most potent inhibitory activities (MIC50 = 8 µg/mL and MIC90 = 16 µg/mL).
Keywords: Helicobacter pylori; Metronidazole Resistance; Nitroimidazole Derivatives; Synthesis.
Copyright © 2023, Bayati et al.
Conflict of interest statement
The authors have no conflict of interest.
Figures
References
-
- Ebrahimi Daryani N, Taher M, Shirzad S. Helicobacter Pylori Infection: A Review. Arch Clin Infect Dis. 2011;6(1):56–64.
-
- Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: A randomised trial. Lancet. 2002;359(9300):9–13. doi: 10.1016/s0140-6736(02)07272-0. - DOI - PubMed
LinkOut - more resources
Full Text Sources